Cyclo(L-Leu-L-Pro)

Cyclo(L-Leu-L-Pro)

* Please be kindly noted products are not for therapeutic use. We do not sell to patients.

Cyclo(L-Leu-L-Pro)
Category Enzyme inhibitors
Catalog number BBF-04358
CAS 2873-36-1
Molecular Weight 210.3
Molecular Formula C11H18N2O2
Purity ≥95%

Ordering Information

Catalog Number Size Price Stock Quantity
BBF-04358 1 g $599 In stock

Online Inquiry

Add to cart

Description

Cyclo (-Leu-Pro) is a cyclic dipeptide containing leucine and proline.

Specification

Synonyms cyclo(Leu-Pro); Cyclo(L-leucyl-L-prolyl)
Storage Store at -20°C
IUPAC Name (3S,8aS)-3-(2-methylpropyl)-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione
Canonical SMILES CC(C)CC1C(=O)N2CCCC2C(=O)N1
InChI InChI=1S/C11H18N2O2/c1-7(2)6-8-11(15)13-5-3-4-9(13)10(14)12-8/h7-9H,3-6H2,1-2H3,(H,12,14)/t8-,9-/m0/s1
InChI Key SZJNCZMRZAUNQT-IUCAKERBSA-N

Properties

Appearance White Solid
Antibiotic Activity Spectrum Neoplastics (Tumor)
Boiling Point 427.6°C at 760 mmHg
Melting Point 163-165°C
Density 1.14 g/cm3
Solubility Soluble in DMSO

Reference Reading

1. Butyrolactone and cycloheptanetrione from mangrove-associated fungus Aspergillus terreus
Yi Shen, Hanlin Ge, Xiuping Cao, Jungui Dai, Jianhua Zou, Dan Xie Chem Pharm Bull (Tokyo) . 2012;60(11):1437-41. doi: 10.1248/cpb.c12-00616.
A new butyrolactone, 7″-hydroxybutyrolactone III (1) and three new cycloheptanetriones, terretrione A-C (2-4), together with five known compounds, butyrolactone I, cyclo(Leu-Pro), cyclo(Val-Pro), cyclo(Ile-Pro), cyclo(Phe-Pro), were isolated from mangrove-associated marine fungus Aspergillus terreus. The structures of these compounds were elucidated on the basis of physical data analysis (NMR, high resolution-electrospray ionization (HR-ESI)-MS), especially by 2D-NMR techniques. These compounds showed weak cytotoxicity in vitro against HCT-8, Bel-7402, BGC-823, A2780 cell lines.
2. Unambiguous Stereochemical Assignment of Cyclo(Phe-Pro), Cyclo(Leu-Pro), and Cyclo(Val-Pro) by Electronic Circular Dichroic Spectroscopy
Alison Domzalski, Yujia Xu, Naga Vara Kishore Pilarsetty, Valeria Vigo, Liliana Margent, Akira Kawamura, Faizunnahar Dewan Molecules . 2021 Oct 2;26(19):5981. doi: 10.3390/molecules26195981.
2,5-diketopiperazines (DKPs) are cyclic dipeptides ubiquitously found in nature. In particular, cyclo(Phe-Pro), cyclo(Leu-Pro), and cyclo(Val-Pro) are frequently detected in many microbial cultures. Each of these DKPs has four possible stereoisomers due to the presence of two chirality centers. However, absolute configurations of natural DKPs are often ambiguous due to the lack of a simple, sensitive, and reproducible method for stereochemical assignment. This is an important problem because stereochemistry is a key determinant of biological activity. Here, we report a synthetic DKP library containing all stereoisomers of cyclo(Phe-Pro), cyclo(Leu-Pro), and cyclo(Val-Pro). The library was subjected to spectroscopic characterization using mass spectrometry, NMR, and electronic circular dichroism (ECD). It turned out that ECD can clearly differentiate DKP stereoisomers. Thus, our ECD dataset can serve as a reference for unambiguous stereochemical assignment of cyclo(Phe-Pro), cyclo(Leu-Pro), and cyclo(Val-Pro) samples from natural sources. The DKP library was also subjected to a biological screening using assays forE. coligrowth and biofilm formation, which revealed distinct biological effects of cyclo(D-Phe-L-Pro).
3. Association of Synergistetes and Cyclodipeptides with Periodontitis
T Morelli, M B Aspiras, S P Barros, W Jenkins, S Offenbacher, M Ward, J T Marchesan, K Moss J Dent Res . 2015 Oct;94(10):1425-31. doi: 10.1177/0022034515594779.
The purpose of this study was to evaluate the microbial community (MC) composition as it relates to salivary metabolites and periodontal clinical parameters in a 21-d biofilm-overgrowth model. Subjects (N = 168) were enrolled equally into 5 categories of periodontal status per the biofilm-gingival interface classification. Microbial species within subgingival plaque samples were identified by human microbiome identification microarray. Whole saliva was analyzed by liquid chromatography-mass spectrometry and gas chromatography-mass spectrometry for metabolite identification. Phylum was grouped into MCs according to principal component analysis. Generalized linear and regression models were used to examine the association among MC, species, periodontal clinical parameters, and salivary metabolome. Multiple comparisons were adjusted with the false discovery rate. The study population was distributed into 8 distinct MC profiles, designated MC-1 to MC-8. MC-2 explained 14% of the variance and was dominated by Synergistetes and Spirochaetes. It was the only community structure significantly associated with high probing depth (P = 0.02) and high bleeding on probing (P = 0.008). MC-2 was correlated with traditional periodontal pathogens and several newly identified putative periodontal pathogens: Fretibacterium fastidiosum, Fretibacterium sp. OT360/OT362, Filifactor alocis, Treponema lecithinolyticum, Eubacterium saphenum, Desulfobulbus sp./OT041, and Mogibacterium timidum. Synergistetes phylum was strongly associated with 2 novel metabolites-cyclo (-leu-pro) and cyclo (-phe-pro)-at 21 d of biofilm overgrowth (P = 0.02). In subjects with severe periodontitis (P2 and P3), cyclo (-leu-pro) and cyclo (-phe-pro) were significantly associated with increased changes in probing depth at 21 d of biofilm overgrowth (P ≤ 0.05). The analysis identified a MC dominated by Synergistetes, with classic and putative newly identified pathogens/pathobionts associated with clinical disease. The metabolomic discovery of 2 novel cyclodipeptides that have been reported to serve as quorum-sensing and/or bacteriocidal/bacteriostatic molecules, in association with Synergistetes, suggests a potential role in periodontal biofilm dysbiosis and periodontal disease that warrants further investigation.

Recommended Products

Bio Calculators

Stock concentration: *
Desired final volume: *
Desired concentration: *

L

* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2

* Total Molecular Weight:
g/mol
Tip: Chemical formula is case sensitive. C22H30N4O c22h30n40
g/mol
g

Recently viewed products

Online Inquiry

Verification code
cartIcon
Inquiry Basket